<SEC-DOCUMENT>0001193125-24-010234-index.html : 20240118 <SEC-HEADER>0001193125-24-010234.hdr.sgml : 20240118 <ACCEPTANCE-DATETIME>20240118163053 ACCESSION NUMBER: 0001193125-24-010234 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20240118 FILED AS OF DATE: 20240118 DATE AS OF CHANGE: 20240118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KAZIA THERAPEUTICS LTD CENTRAL INDEX KEY: 0001075880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: C3 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29962 FILM NUMBER: 24542216 BUSINESS ADDRESS: STREET 1: THREE INTERNATIONAL TOWERS LEVEL 24, STREET 2: 300 BARANGAROO AVENUE CITY: SYDNEY NSW STATE: C3 ZIP: 2000 BUSINESS PHONE: 01161298780088 MAIL ADDRESS: STREET 1: THREE INTERNATIONAL TOWERS LEVEL 24, STREET 2: 300 BARANGAROO AVENUE CITY: SYDNEY NSW STATE: C3 ZIP: 2000 FORMER COMPANY: FORMER CONFORMED NAME: NOVOGEN LTD DATE OF NAME CHANGE: 19981228 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>d620838d6k.htm <DESCRIPTION>6-K <TEXT> Document 1 - file: d620838d6k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>d620838dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: d620838dex991.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>g620838g48h22.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: g620838g48h22.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g620838g97f50.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g620838g97f50.jpg
</DOCUMENT> </SEC-DOCUMENT>